Giovanni Manfredi Assanto

Impact of anti‐SARS‐CoV‐2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study

Giovanni Manfredi Assanto, Alice Di Rocco, Francesco Malfona et al. · Hematological Oncology · 2022 · 17 citations · Full text

The current role of interferon in hairy cell leukaemia: clinical and molecular aspects

Giovanni Manfredi Assanto, Costantino Riemma, Francesco Malaspina et al. · British Journal of Haematology · 2021 · 15 citations · Full text

Hematological Malignancy, Complete Response Rate, Medicine +12

RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort

Emilia Scalzulli, Claudia Ielo, Cristina Luise et al. · Blood Advances · 2022 · 15 citations · Full text

Hematological Malignancy, Oncology, Prognosis +7

Reduced transmission of <i>Klebsiella pneumoniae</i> carbapenemase-producing <i>K. pneumoniae</i> (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic

Alessandra Micozzi, Giovanni Manfredi Assanto, Laura Cesini et al. · JAC-Antimicrobial Resistance · 2021 · 14 citations · Full text

Whole body MRI with Diffusion Weighted Imaging versus 18F-fluorodeoxyglucose-PET/CT in the staging of lymphomas

Francesca Maccioni, Giulia Alfieri, Giovanni Manfredi Assanto et al. · La radiologia medica · 2023 · 13 citations · Full text